The trademark application was filed by AmyriAD Therapeutics B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on July 25, 2021, and it was registered by office on November 1, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1640158 at the World Intellectual Property Organization (WIPO).
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on July 4, 2021. Change of name and address of the trademark registration was recorded on July 14, 2021.